and the Acute Liver Failure Study Group Acute liver failure (ALF) due to drug-induced liver injury (DILI), though uncommon, is a concern for both clinicians and patients. The Acute Liver Failure Study Group has prospectively collected cases of all forms of acute liver failure since 1998. We describe
Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study
โ Scribed by Reuben, Adrian (author);Koch, David G. (author);Lee, William M. (author)
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 163 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In addition to the hypothetical liver vulnerability of homozygous CCR5-โฌ32 patients, it seems that CCR5 de ficiency may increase the susceptibility to other diseases. Preliminary results from our laboratory also suggest that CCR5-deficient mice disclose higher susceptibility to experimental pancrea
Severe acetaminophen hepatotoxicity frequently leads to acute liver failure (ALF). We determined the incidence, risk factors, and outcomes of acetaminophen-induced ALF at 22 tertiary care centers in the United States. Detailed prospective data were gathered on 662 consecutive patients over a 6-year
Acetaminophen overdose is the leading cause for calls to Poison Control Centers (>100,000/year) and accounts for more than 56,000 emergency room visits, 2,600 hospitalizations, and an estimated 458 deaths due to acute liver failure each year. Data from the U.S. Acute Liver Failure Study Group regist
It is widely perceived that outcomes are relatively poor following retransplantation (reTX) for recurrent of hepatitis C virus (HCV) infection. Transplant centers debate the utility of offering another liver to these patients. A U.S. study group was formed to retrospectively compare survival after r